908 Devices Inc Total Assets
908 Devices Inc total assets. Based on the latest financial reports, 908 Devices Inc (MASS) holds total assets worth $186.69 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see 908 Devices Inc stock valuation for the company's overall valuation and market capitalisation.
Total Assets of 908 Devices Inc (2018–2025)
Total assets of 908 Devices Inc from 2018 to 2025. This chart illustrates how 908 Devices Inc's total assets have evolved over time, based on quarterly financial data. See current stock price of 908 Devices Inc for real-time trading data and today's change.
908 Devices Inc - Asset Composition Analysis
908 Devices Inc Total Assets Breakdown (December 2025)
908 Devices Inc total assets breakdown as of December 2025. 908 Devices Inc's total assets of $186.69 Million consist of 76.1% current assets and 23.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 59.4% |
| Accounts Receivable | $11.33 Million | 6.0% |
| Inventory | $12.99 Million | 6.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $36.41 Million | 19.2% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2018–2025)
This chart illustrates how 908 Devices Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore MASS working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: 908 Devices Inc's current assets represent 76.1% of total assets in 2025, an increase from 62.0% in 2018.
- Cash Position: Cash and equivalents constituted 59.4% of total assets in 2025, up from 25.5% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 19.0% of total assets, an increase from 0.0% in 2018.
- Asset Diversification: The largest asset category is intangible assets at 19.2% of total assets.
908 Devices Inc Competitors by Total Assets
Key competitors of 908 Devices Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥916.43 Million |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Applied BioCode
TW:6598
|
Taiwan | NT$1.03 Billion |
|
Oncosil Medical Ltd
AU:OSL
|
Australia | AU$7.13 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Cleo Diagnostics Ltd
AU:COV
|
Australia | AU$9.96 Million |
|
Radiant Innovation
TWO:3373
|
Taiwan | NT$859.52 Million |
|
MedX Health Corp
V:MDX
|
Canada | CA$1.26 Million |
908 Devices Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.58 | 7.62 | 14.06 |
| Quick Ratio | 3.25 | 6.97 | 13.35 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $102.35 Million | $129.44 Million | $146.01 Million |
908 Devices Inc - Advanced Valuation Insights
This section examines the relationship between 908 Devices Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.49 |
| Latest Market Cap to Assets Ratio | 1.58 |
| Asset Growth Rate (YoY) | 19.2% |
| Total Assets | $190.07 Million |
| Market Capitalization | $299.86 Million USD |
Valuation Analysis
Above Book Valuation: The market values 908 Devices Inc's assets above their book value (1.58x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: 908 Devices Inc's assets grew by 19.2% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for 908 Devices Inc (2018–2025)
The table below shows the annual total assets of 908 Devices Inc from 2018 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $190.07 Million | +19.18% |
| 2024-12-31 | $159.48 Million | -21.43% |
| 2023-12-31 | $202.98 Million | -16.33% |
| 2022-12-31 | $242.59 Million | -7.02% |
| 2021-12-31 | $260.91 Million | +45.90% |
| 2020-12-31 | $178.83 Million | +374.82% |
| 2019-12-31 | $37.66 Million | +35.73% |
| 2018-12-31 | $27.75 Million | -- |
About 908 Devices Inc
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spe… Read more